164 related articles for article (PubMed ID: 32242512)
1. Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor Therapy.
Zhou C; Zhu HL; Duan Y
Curr Top Med Chem; 2020; 20(5):333-335. PubMed ID: 32242512
[No Abstract] [Full Text] [Related]
2. The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors.
Su J; Wang X; Bai Y; Sun M; Yao Y; Duan Y
Pharmacol Res; 2021 Dec; 174():105930. PubMed ID: 34626770
[TBL] [Abstract][Full Text] [Related]
3. A small molecule inhibitor of fungal histone acetyltransferase Rtt109.
Lopes da Rosa J; Bajaj V; Spoonamore J; Kaufman PD
Bioorg Med Chem Lett; 2013 May; 23(10):2853-9. PubMed ID: 23587423
[TBL] [Abstract][Full Text] [Related]
4. Targeting Histone Lysine Demethylase LSD1/KDM1A as a New Avenue for Cancer Therapy.
Fang Y; Liao G; Yu B
Curr Top Med Chem; 2019; 19(11):889-891. PubMed ID: 31389779
[No Abstract] [Full Text] [Related]
5. Small molecule inhibitors of histone acetyltransferase Tip60.
Wu J; Wang J; Li M; Yang Y; Wang B; Zheng YG
Bioorg Chem; 2011 Feb; 39(1):53-8. PubMed ID: 21186043
[TBL] [Abstract][Full Text] [Related]
6. Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity.
Ganai SA
Curr Top Med Chem; 2016; 16(4):427-34. PubMed ID: 26268342
[TBL] [Abstract][Full Text] [Related]
7. Histone acetyltransferase inhibitors: where art thou?
Baell JB; Miao W
Future Med Chem; 2016 Sep; 8(13):1525-8. PubMed ID: 27557114
[No Abstract] [Full Text] [Related]
8. MOZ/KAT6A: a promising target for acute myeloid leukemia therapy.
Zhou C; Liu W; Duan Y
Future Med Chem; 2020 May; 12(9):759-761. PubMed ID: 32212924
[No Abstract] [Full Text] [Related]
9. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
Furdas SD; Kannan S; Sippl W; Jung M
Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
[TBL] [Abstract][Full Text] [Related]
10. Current development of CBP/p300 inhibitors in the last decade.
He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer using KAT inhibitors to mimic lethal knockouts.
Brown JA; Bourke E; Eriksson LA; Kerin MJ
Biochem Soc Trans; 2016 Aug; 44(4):979-86. PubMed ID: 27528742
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screening.
Zhang R; Wang J; Zhao L; Liu S; Du D; Ding H; Chen S; Yue L; Liu YC; Zhang C; Liu H; Luo C
Eur J Med Chem; 2018 Sep; 157():867-876. PubMed ID: 30145373
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A.
Leaver DJ; Cleary B; Nguyen N; Priebbenow DL; Lagiakos HR; Sanchez J; Xue L; Huang F; Sun Y; Mujumdar P; Mudududdla R; Varghese S; Teguh S; Charman SA; White KL; Katneni K; Cuellar M; Strasser JM; Dahlin JL; Walters MA; Street IP; Monahan BJ; Jarman KE; Sabroux HJ; Falk H; Chung MC; Hermans SJ; Parker MW; Thomas T; Baell JB
J Med Chem; 2019 Aug; 62(15):7146-7159. PubMed ID: 31256587
[TBL] [Abstract][Full Text] [Related]
15. Action plan for hit identification (APHID): KAT6A as a case study.
Yi X; Xue L; Thomas T; Baell JB
Future Med Chem; 2020 Mar; 12(5):423-437. PubMed ID: 32064938
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
17. Tip60: Main Functions and Its Inhibitors.
Zhang X; Wu J; Luan Y
Mini Rev Med Chem; 2017; 17(8):675-682. PubMed ID: 27670582
[TBL] [Abstract][Full Text] [Related]
18. Advancing the kinase field: new targets and second generation inhibitors.
Laufer S; Bajorath J
J Med Chem; 2015 Jan; 58(1):1. PubMed ID: 25490234
[No Abstract] [Full Text] [Related]
19. When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?
Rani R; Kumar V
Future Med Chem; 2017 Jul; 9(11):1113-1115. PubMed ID: 28722474
[No Abstract] [Full Text] [Related]
20. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
